Bier H - Search Results

1

Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.

Bas M, Bier H, Schirlau K, Friebe-Hoffmann U, Scheckenbach K, Balz V, Whiteside TL, Hoffmann TK. Bas M, et al. Among authors: bier h. Oral Oncol. 2006 Aug;42(7):691-7. doi: 10.1016/j.oraloncology.2005.11.008. Epub 2006 Mar 9. Oral Oncol. 2006. PMID: 16527515

2

Chemotherapeutic drug resistance in the management of head and neck cancer.

Bier H. Bier H. Eur Arch Otorhinolaryngol. 1993;250(4):200-8. doi: 10.1007/BF00171524. Eur Arch Otorhinolaryngol. 1993. PMID: 8369114 Review.

3

Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.

Koldovsky P, Haas I, Bier H, Ganzer U. Koldovsky P, et al. Among authors: bier h. Eur Arch Otorhinolaryngol. 1995;252(6):359-65. doi: 10.1007/BF00178278. Eur Arch Otorhinolaryngol. 1995. PMID: 8679156

4

Chemosensitivity of head and neck squamous carcinoma cell lines is not primarily correlated with glutathione level but is modified by glutathione depletion.

Bier H, Hoffmann T, Eickelmann P, Hafner D. Bier H, et al. J Cancer Res Clin Oncol. 1996;122(11):653-8. doi: 10.1007/BF01209027. J Cancer Res Clin Oncol. 1996. PMID: 8898974

5

Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.

Hoffmann T, Hafner D, Ballo H, Haas I, Bier H. Hoffmann T, et al. Among authors: bier h. Anticancer Res. 1997 Nov-Dec;17(6D):4419-25. Anticancer Res. 1997. PMID: 9494544

6

Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck.

Bier H, Hoffmann T, Haas I, van Lierop A. Bier H, et al. Cancer Immunol Immunother. 1998 May;46(3):167-73. doi: 10.1007/s002620050475. Cancer Immunol Immunother. 1998. PMID: 9625540 Free PMC article.

7

Establishment and characterization of four cell lines derived from human head and neck squamous cell carcinomas for an autologous tumor-fibroblast in vitro model.

Balló H, Koldovsky P, Hoffmann T, Balz V, Hildebrandt B, Gerharz CD, Bier H. Balló H, et al. Among authors: bier h. Anticancer Res. 1999 Sep-Oct;19(5B):3827-36. Anticancer Res. 1999. PMID: 10628319

8

Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck.

Hoffmann TK, Balló H, Braunstein S, Van Lierop A, Wagenmann M, Bier H. Hoffmann TK, et al. Among authors: bier h. Oral Oncol. 2001 Jan;37(1):50-6. doi: 10.1016/s1368-8375(00)00056-7. Oral Oncol. 2001. PMID: 11120483

9

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx.

Bier H, Hoffmann T, Hauser U, Wink M, Ochler M, Kovar A, Müser M, Knecht R. Bier H, et al. Cancer Chemother Pharmacol. 2001 Jun;47(6):519-24. doi: 10.1007/s002800000270. Cancer Chemother Pharmacol. 2001. PMID: 11459205 Clinical Trial.

10

Antitumor activity of protein kinase C inhibitors and cisplatin in human head and neck squamous cell carcinoma lines.

Hoffmann TK, Leenen K, Hafner D, Balz V, Gerharz CD, Grund A, Balló H, Hauser U, Bier H. Hoffmann TK, et al. Among authors: bier h. Anticancer Drugs. 2002 Jan;13(1):93-100. doi: 10.1097/00001813-200201000-00011. Anticancer Drugs. 2002. PMID: 11914646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters